Medicalsystem Biotechnology Co., Ltd (SHE:300439)
China
· Delayed Price · Currency is CNY 10.34
+0.16 (1.57%)
Mar 10, 2026, 3:04 PM CST
SHE:300439 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 3,912 | 4,012 | 4,447 | 4,481 | 8,162 | 6,267 | Upgrade
|
| Market Cap Growth | -5.48% | -9.77% | -0.77% | -45.10% | 30.24% | 33.54% | Upgrade
|
| Enterprise Value | 3,054 | 3,217 | 3,671 | 4,153 | 8,093 | 7,130 | Upgrade
|
| Last Close Price | 10.18 | 10.31 | 11.28 | 11.27 | 20.36 | 17.32 | Upgrade
|
| PE Ratio | 41.64 | 15.55 | 17.33 | 22.57 | 45.47 | 20.93 | Upgrade
|
| Forward PE | - | 17.42 | 17.42 | 17.42 | 17.42 | 17.42 | Upgrade
|
| PS Ratio | 2.66 | 2.30 | 2.36 | 1.80 | 3.63 | 2.72 | Upgrade
|
| PB Ratio | 1.33 | 1.37 | 1.64 | 1.78 | 3.41 | 3.72 | Upgrade
|
| P/TBV Ratio | 1.39 | 1.43 | 1.72 | 1.88 | 3.71 | 4.28 | Upgrade
|
| P/FCF Ratio | 33.82 | - | 12.59 | 17.13 | 26.02 | 11.85 | Upgrade
|
| P/OCF Ratio | 9.02 | 10.09 | 7.02 | 7.94 | 15.83 | 6.87 | Upgrade
|
| EV/Sales Ratio | 2.08 | 1.85 | 1.95 | 1.67 | 3.60 | 3.10 | Upgrade
|
| EV/EBITDA Ratio | 11.60 | 7.48 | 9.57 | 10.21 | 19.64 | 16.24 | Upgrade
|
| EV/EBIT Ratio | 101.14 | 13.37 | 15.89 | 17.55 | 33.92 | 26.84 | Upgrade
|
| EV/FCF Ratio | 26.40 | - | 10.39 | 15.88 | 25.80 | 13.49 | Upgrade
|
| Debt / Equity Ratio | 0.02 | 0.03 | 0.03 | 0.13 | 0.20 | 0.55 | Upgrade
|
| Debt / EBITDA Ratio | 0.17 | 0.19 | 0.23 | 0.77 | 1.11 | 2.11 | Upgrade
|
| Debt / FCF Ratio | 0.39 | - | 0.26 | 1.27 | 1.54 | 1.75 | Upgrade
|
| Net Debt / Equity Ratio | -0.29 | -0.28 | -0.32 | -0.22 | -0.12 | 0.36 | Upgrade
|
| Net Debt / EBITDA Ratio | -3.44 | -1.90 | -2.27 | -1.36 | -0.69 | 1.36 | Upgrade
|
| Net Debt / FCF Ratio | -7.36 | 35.95 | -2.47 | -2.12 | -0.91 | 1.13 | Upgrade
|
| Asset Turnover | 0.41 | 0.48 | 0.53 | 0.69 | 0.66 | 0.66 | Upgrade
|
| Inventory Turnover | 3.46 | 3.57 | 4.45 | 7.23 | 5.79 | 4.44 | Upgrade
|
| Quick Ratio | 2.46 | 2.21 | 2.25 | 1.81 | 1.55 | 0.90 | Upgrade
|
| Current Ratio | 3.12 | 2.73 | 2.72 | 2.11 | 1.89 | 1.13 | Upgrade
|
| Return on Equity (ROE) | 3.37% | 9.31% | 9.93% | 8.36% | 9.33% | 19.09% | Upgrade
|
| Return on Assets (ROA) | 0.52% | 4.18% | 4.08% | 4.12% | 4.36% | 4.75% | Upgrade
|
| Return on Invested Capital (ROIC) | 1.45% | 11.33% | 10.67% | 10.69% | 9.47% | 9.48% | Upgrade
|
| Return on Capital Employed (ROCE) | 1.00% | 7.90% | 8.30% | 9.10% | 9.40% | 14.20% | Upgrade
|
| Earnings Yield | 2.41% | 6.43% | 5.77% | 4.43% | 2.20% | 4.78% | Upgrade
|
| FCF Yield | 2.96% | -0.57% | 7.94% | 5.84% | 3.84% | 8.44% | Upgrade
|
| Dividend Yield | 1.32% | 1.31% | 1.19% | 0.93% | 0.47% | 0.91% | Upgrade
|
| Payout Ratio | 55.67% | 20.34% | 19.44% | 25.54% | 50.92% | 41.86% | Upgrade
|
| Buyback Yield / Dilution | -0.42% | -0.56% | -0.30% | -2.10% | -8.59% | -0.24% | Upgrade
|
| Total Shareholder Return | 0.90% | 0.74% | 0.89% | -1.17% | -8.13% | 0.66% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.